GLAXOSMITHKLINE PLC 13D and 13G filings for CRISPR Therapeutics AG:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
2020-07-10 5:26 pm Purchase |
2020-07-06 | 13D | CRISPR Therapeutics AG CRSP |
GLAXOSMITHKLINE PLC | 3,310,627 4.800% |
15,000![]() (+0.46%) |
Filing |